Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data

CONCLUSIONS: The study shows that mUC is associated with significant HCRU and costs across different types of 1 L systemic therapy.PMID:38639988 | DOI:10.1080/13696998.2024.2331893

Source: Journal of Medical Economics - April 19, 2024 Category: Health Management Authors: G ünter Niegisch Marc-Oliver Grimm Fraence Hardtstock Julia Krieger Alexandra Starry Ulrike Osowski Barthold Deiters Ulf Maywald Thomas Wilke Mairead Kearney Source Type: research